AbCellera Biologics Inc.
ABCLNasdaqCIK 1703057HealthcareFiscal year ends Dec 31
Reports and events: 102 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2023-10-1320:03 ET | 8-K | 8.01 Other events | 0001703057-23-000034 |
| 2023-08-0316:33 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001703057-23-000022 |
| 2023-08-0316:15 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001703057-23-000020 |
| 2023-06-2016:56 ET | 8-K | 5.07 Shareholder vote results | 0001703057-23-000014 |
| 2023-05-2414:36 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001703057-23-000011 |
| 2023-05-0416:57 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001703057-23-000008 |
| 2023-05-0416:39 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001703057-23-000005 |
| 2023-04-2816:52 ET | DEF 14A | Proxy statement | 0001140361-23-021664 |
| 2023-04-2416:53 ET | SC 13D/A | Ownership report, active investor, amended | 0001104659-23-049066 |
| 2023-03-1318:14 ET | 8-K | 7.01 Regulation FD disclosure | 0001564590-23-003427 |
| 2023-02-2117:04 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001564590-23-002128 |
| 2023-02-2116:51 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001564590-23-002126 |
| 2022-11-0816:47 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001564590-22-037060 |
| 2022-11-0816:31 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001564590-22-037057 |
| 2022-08-0916:42 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001564590-22-028784 |
| 2022-08-0916:26 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001564590-22-028771 |
| 2022-07-2216:53 ET | 10-K/A | Annual report, amendedPeriod 2021-12-31 | 0001564590-22-026266 |
| 2022-07-1917:42 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001564590-22-025922 |
| 2022-07-0616:57 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001564590-22-025392 |
| 2022-06-3013:28 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001564590-22-024914 |
| 2022-06-2112:28 ET | 8-K | 5.07 Shareholder vote results | 0001564590-22-023707 |
| 2022-05-1016:23 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001564590-22-019294 |
| 2022-05-1016:17 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001564590-22-019285 |
| 2022-04-2814:33 ET | DEF 14A | Proxy statementPeriod 2022-06-15 | 0001140361-22-016463 |
| 2022-02-2514:09 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001564590-22-007077 |
| 2022-02-2417:02 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001564590-22-006755 |
| 2022-02-1517:18 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001564590-22-005256 |
| 2021-12-0716:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001564590-21-059570 |
| 2021-12-0313:38 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001564590-21-059298 |
| 2021-11-1016:16 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001564590-21-056205 |
| 2021-11-0917:00 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001564590-21-055806 |
| 2021-11-0416:17 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001564590-21-054498 |
| 2021-09-2317:42 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001564590-21-048621 |
| 2021-09-1516:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001564590-21-048042 |
| 2021-08-1316:31 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001564590-21-044327 |
| 2021-08-1217:21 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001564590-21-044061 |
| 2021-07-1316:29 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001564590-21-036460 |
| 2021-06-2116:33 ET | 8-K | 5.07 Shareholder vote results | 0001564590-21-033639 |
| 2021-06-1017:18 ET | S-1 | Registration statement | 0001193125-21-187930 |
| 2021-05-1716:05 ET | 8-K/A | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001564590-21-028375 |
| 2021-05-1416:05 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0001564590-21-028008 |
| 2021-05-1316:30 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001564590-21-027597 |
| 2021-04-2816:00 ET | DEF 14A | Proxy statementPeriod 2021-06-15 | 0001140361-21-014738 |
| 2021-04-0107:48 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-21-103256 |
| 2021-03-3017:08 ET | 10-K | Annual reportPeriod 2020-12-31 | 0001564590-21-016713 |
| 2021-03-2916:29 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001564590-21-016135 |
| 2021-03-0209:01 ET | 8-K | 8.01 Other events | 0001193125-21-064713 |
| 2020-12-2816:48 ET | SC 13D | Ownership report, active investor | 0001068238-20-000249 |
| 2020-12-1008:37 ET | S-1/A | Registration statement, amended | 0001193125-20-314458 |
| 2020-12-0706:06 ET | S-1/A | Registration statement, amended | 0001193125-20-311091 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 15, 2026, 01:06 ET. Listed shows no prices and gives no investment advice.